Prices land at 8:30 a.m., after this email. Brookfield is selling half of Enercare. At Monday's close, CKX's leftover stock was priced at about 5.7 times the Jacobs group's price.

THE NUMBER

88 cents.

That is where Kalshi's contract on a December rate hike traded at about 6:30 a.m. It was near 81 cents at 4 a.m. Within 20 minutes it reached 89, and it briefly touched 90. No news has been tied to the jump. At 8:30 a.m., after this email, October consumer prices land. Forecasters expect a 0.3% rise for the month, and 0.2% without food and energy.

The bond market had already leaned this way. On Monday, the two-year Treasury yield rose to about 4.56% while Brent fell nearly 6%. Two Fed presidents pointed to costs that oil does not touch. Variable-rate borrowers would pay more after a hike. Savers could earn more on cash.

A soft core number would test that bet.

THE SETUP
  • The S&P 500 had its best day since April on Monday. By about 6:30 a.m., Dow futures were up and Nasdaq-100 futures were down slightly. SoftBank closed 13.9% higher in Tokyo, then reported a ¥1.1 trillion quarterly loss after the close.
  • A shareholder sued Nvidia and CEO Jensen Huang over statements the company and Huang made. President Trump said the FBI is looking into it, without saying what it is examining. House committee chairs want Huang's reply by Wednesday. Nvidia was slightly higher before the bell.
  • CoreWeave reports after the close.
PMD Signal Tracker

IN FOCUS

Brent Dipped Below $90 Before Dawn. Trump Plans to Hold Off on New Iran Strikes for Now and Keep the Blockade, a Report Said.

Brent fell to about $89.20 shortly before 5 a.m., then climbed back. By about 6:30 a.m., it was near $91, still down more than 1% overnight. On Monday it fell nearly 6%. The bigger part of the drop came as the diplomatic news got worse.

Trump met Qatar's prime minister on Monday. He plans to hold off on new strikes for now, a report said. He also plans to keep the naval blockade in the Strait of Hormuz. No deal was announced.

On Monday, PMD said one reading was that traders now price the odds of new U.S. strikes more than the count of attacks. The report of Trump's plan came later. The slide was underway before the meeting. Morgan Stanley said Dated Brent, the physical benchmark, had slipped below nearby futures.

The Threat Eased. The Blockade Did Not.

One reading: the fear of new U.S. strikes is leaving the price. Another: the market has more barrels than buyers, deal or no deal. A bounce on bad news from the Gulf would favor the first. A slide on bad news would favor the second. The government's short-term energy outlook lands today.

FROM OUR PARTNERS

1 Free Thing American Citizens Can Do to Target More Income

It's not investing in CDs, Treasurys, or even getting a second job. Wall Street insider Rob Spivey has uncovered an income engine hidden beneath Elon's empire. He calls it Elon's "Shadow Trust." It consists of a handful of little-know companies that have paid out a steady stream of income going back 20 years... They've paid out $4 billion in the past 12 months… over $100 million in the past few weeks…and the next payout hits soon. Details here…

This ad is sent on behalf of Altimetry, 110 Cambridge Street, Cambridge, MA 02141. If you would like to optout from receiving offers from Altimetry please click here.

SIGNALS IN MOTION

SIGNAL 1: GFL Turned Down $52 a Share From Blackstone, KKR and ECP, a Report Said. Early Tuesday, Its Shares Were About 15% Lower.

GFL Environmental's board rejected a $52-a-share offer to take the waste hauler private, The Globe and Mail reported late Monday, citing two sources. The bidders were Blackstone, KKR and Energy Capital Partners. The offer was about 13% above Monday's close of $45.88. The board wanted $58 or more, and the group would not raise its bid. GFL had issued no statement by about 6:30 a.m.

Three big buyers, bidding together, would not close a gap of about $6 a share. In thin trading before the bell, GFL was quoted near $39.

WHAT RESOLVES THIS

GFL's own statement on its review, expected Tuesday, and where the shares settle after the open.

SIGNAL 2: Brookfield Is Selling Half of Enercare to PSP for About C$1.6 Billion. It Keeps the Other Half.

PSP Investments, a Canadian pension investor, agreed to buy 50% of Enercare from Brookfield and its partners. The price is about C$1.6 billion. Enercare is a Canadian home-infrastructure company. PSP invested alongside Brookfield when it took Enercare private in 2018. The deal should close in the first half of 2027.

KKR said Monday it expects to return more than $40 billion to its clients this year. A half sale to a known partner is another way to send cash back without a full exit or a listing. Neither side gave a value for the whole company or its debt. So C$1.6 billion should not be doubled into a total value.

WHAT RESOLVES THIS

Approvals before the 2027 close, and whether other sponsors sell half stakes to their own partners.

SIGNAL 3: Brad Jacobs' Group Will Put $1 Billion Into CKX Lands. At Monday's Close, the Leftover Stock Was Priced at About 5.7 Times the Investors' Price.

Jacobs Private Equity and co-investors agreed to put $1 billion in cash into CKX Lands, a tiny Louisiana land company. After a reverse split, they will convert at $4.57 a share and own about 99.78%, before warrants. Holders of record shortly before closing get a special dividend of about $10.13 a share. CKX rose 58% on Monday, to $16.40.

Take out the dividend and adjust for the split, and the rest is priced at about 5.7 times the investors' price. That is math from the terms and Monday's close, not a value for the business. Only about 1.3 million shares trade freely. Nearly 12 million changed hands Monday.

Jacobs used a near-identical setup at SilverSun, now QXO, in 2023. On the day that deal closed, QXO traded at about 48 times its conversion price. By the end of 2024, it was about 3.5 times. The price path alone does not show why.

WHAT RESOLVES THIS

The proxy, not yet dated, should show how the land business is treated and when holders vote. Closing is expected in early 2027.

PARTNER SPOTLIGHT

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why

The world's wealthiest individuals are making huge moves with their money.

Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion.

What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t seen in America for more than a century.

For the full story, click here.

WHAT MOST WILL MISS
  • MARA sold about 40% of its bitcoin after Sept. 30, about 13,600 coins for about $1.1 billion. The miner repaid all its bitcoin-backed loans. It said it expects to sell more, but gave no amount.
  • Australia's securities regulator reviewed 24 private credit funds. Nine of the 12 sold to retail investors failed to clearly explain key facts, including distressed assets. ASIC has issued six interim stop orders since September.
THE CROSSOVER

Private Market Trends Driving Public Market Moves

One Bid Walked and One Buyer Arrived. The Two Stocks Moved Far Apart.

Three sponsors would not go to $58 for GFL, a report said, and its shares were bid about 15% lower early Tuesday. At Monday's close, CKX's leftover stock was priced at about 5.7 times what Jacobs' group will pay. Brookfield priced half of Enercare with a partner it already knew, away from the market. One reading: public holders pay up when a known buyer arrives and mark down when one walks. Another: thin trading in both stocks overstates the moves, and the open will show more.

On the calendar...

When

Event

Tue., Nov. 10

October consumer prices, 8:30 a.m.; 10-year note sale, 1 p.m.; CoreWeave reports after the close

Wed., Nov. 11

Veterans Day, bond market closed; Huang's reply to House chairs due; MSCI index decision

Thu., Nov. 12

30-year bond sale; weekly government oil data

Tue., Nov. 17

Nvidia reports

Wed., Dec. 9

Fed decision

Big Pharma’s new ‘AI co-scientist’

…is already at work inside Bristol Myers Squibb.

Free report here →